Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study.
Journal: Translational oncology
Published: August 19, 2021
Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma.
Journal: Leukemia & lymphoma
Published: February 15, 2021
Plasma Cell Myeloma Presenting With Amyloid-Laden Crystal-Negative Histiocytosis.
Journal: American journal of clinical pathology
Published: July 25, 2020
Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (177Lu-J591) for metastatic castration-resistant prostate cancer.
Journal: Urologic oncology
Published: March 05, 2020
Pilot Study of Hyperfractionated Dosing of Lutetium-177-Labeled Antiprostate-Specific Membrane Antigen Monoclonal Antibody J591 (177 Lu-J591) for Metastatic Castration-Resistant Prostate Cancer.
Journal: The oncologist
Published: October 25, 2019
Invasive granulomatous cryptococcal sinusitis in an adult with multiple myeloma.
Journal: Clinical imaging
Published: July 24, 2016
Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma.
Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 16, 2016
Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody.
Journal: Current radiopharmaceuticals
Published: November 21, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026